Author:
Lucas Lucas Cristina,García Zoghby Laura,Amo-Salas Mariano,Soriano Castrejón Ángel María,García Vicente Ana María
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference37 articles.
1. Klingenberg S, Jochumsen MR, Ulhøi BP, Fredsøe J, Sørensen KD, Borre M, et al. 68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer. J Nucl Med. 2021;62(2):214–20.
2. Mottet N, Cornford P, Van den Bergh RCN, Briers E, De Santis M, Gillessen S, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate cancer. Eur Urol [internet] 2022. https://uroweb.org/guidelines/prostate-cancer/chapter/citation-information.
3. Evangelista L, Cimitan M, Zattoni F, Gutilla A, Zattoni F, Saladini G. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F] Choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- to high-risk prostate cancer: a retrospective analysis. Scand J Urol. 2015;49(5):345–53.
4. Poulsen MH, Petersen H, Hoilund-Carlsen PF, Jakobsen JS, Gerke O, Karstoft J, et al. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [18F] Choline positron emission tomography (PET)/computed tomography (CT) and [18F]NaF PET/CT. BJU Int. 2014;114(6):818–23.
5. Pinaquy JB, De Clermont-Galleran H, Pasticier G, Rigou G, Alberti N, Hindie E, et al. Comparative effectiveness of 18F-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer. Prostate. 2015;75(3):323–31.